Daver, N., Boddu, P., Garcia-Manero, G., Yadav, S., Sharma, P., Allison, J., & Kantarjian, H. (2018). Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes. Leukemia, 32(5), 1094-1105. https://doi.org/10.1038/s41375-018-0070-8

Boddu, P., Kantarjian, H., Garcia-Manero, G., Allison, J., Sharma, P., & Daver, N. (2018). The emerging role of immune checkpoint based approaches in AML and MDS. Leukemia & Lymphoma, 59(4), 790-802. https://doi.org/10.1080/10428194.2017.1344905

Cortés, J., Podoltsev, N., Kantarjian, H., Borthakur, G., Zeidan, A., Stahl, M., … Uy, G. (2021). Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia. International Journal of Hematology, 113(1), 92-99. https://doi.org/10.1007/s12185-020-02994-8